Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 1.270
+0.048 (3.93%)
Jul 24, 2026, 5:29 PM CET
Intervacc AB Market Cap
Intervacc AB has a market cap or net worth of 416.47 million as of July 24, 2026. Its market cap has increased by 23.43% in one year.
Market Cap
416.47M
Enterprise Value
271.20M
Revenue
18.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.27
ChartMarket Cap Chart
Since April 7, 2017, Intervacc AB's market cap has increased from 85.80M to 416.47M, an increase of 385.43%. That is a compound annual growth rate of 18.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 381.03M | 21.00% |
| Dec 30, 2025 | 314.91M | 255.38% |
| Dec 30, 2024 | 88.61M | -81.52% |
| Dec 29, 2023 | 479.41M | -63.48% |
| Dec 30, 2022 | 1.31B | -50.81% |
| Dec 30, 2021 | 2.67B | 0.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Infant Bacterial Therapeutics AB | 883.73M |
| AlzeCure Pharma AB | 877.03M |
| Xspray Pharma AB | 738.75M |
| Oncopeptides AB | 648.27M |
| FluoGuide | 536.26M |
| Cantargia AB | 472.36M |
| Corline Biomedical AB | 454.72M |
| Mendus AB | 414.10M |